EP3672572A4 - Novel ophthalmic composition and methods of use - Google Patents

Novel ophthalmic composition and methods of use Download PDF

Info

Publication number
EP3672572A4
EP3672572A4 EP17922730.1A EP17922730A EP3672572A4 EP 3672572 A4 EP3672572 A4 EP 3672572A4 EP 17922730 A EP17922730 A EP 17922730A EP 3672572 A4 EP3672572 A4 EP 3672572A4
Authority
EP
European Patent Office
Prior art keywords
methods
ophthalmic composition
novel ophthalmic
novel
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP17922730.1A
Other languages
German (de)
French (fr)
Other versions
EP3672572A1 (en
Inventor
Joseph CAPRIOTTI
Kara CAPRIOTTI
Jesse PELLETIER
Kevin Stewart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Veloce Biopharma LLC
Original Assignee
Veloce Biopharma LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veloce Biopharma LLC filed Critical Veloce Biopharma LLC
Publication of EP3672572A1 publication Critical patent/EP3672572A1/en
Publication of EP3672572A4 publication Critical patent/EP3672572A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
EP17922730.1A 2017-08-22 2017-08-22 Novel ophthalmic composition and methods of use Withdrawn EP3672572A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2017/048063 WO2019040051A1 (en) 2017-08-22 2017-08-22 Novel ophthalmic composition and methods of use

Publications (2)

Publication Number Publication Date
EP3672572A1 EP3672572A1 (en) 2020-07-01
EP3672572A4 true EP3672572A4 (en) 2021-01-06

Family

ID=65439513

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17922730.1A Withdrawn EP3672572A4 (en) 2017-08-22 2017-08-22 Novel ophthalmic composition and methods of use

Country Status (3)

Country Link
EP (1) EP3672572A4 (en)
PH (1) PH12020550059A1 (en)
WO (1) WO2019040051A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126127A (en) * 1991-07-16 1992-06-30 Euroceltique, S.A. Stabilized PVP-I solutions
US20170071979A1 (en) * 2011-05-11 2017-03-16 Veloce Biopharma, Llc Composition and method for treating otitis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016209550A1 (en) * 2015-01-20 2017-08-03 Veloce Biopharma Llc Novel iodophor composition and methods of use
US9770466B2 (en) * 2015-07-02 2017-09-26 Veloce Biopharma, Llc Ophthalmic composition and methods of use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126127A (en) * 1991-07-16 1992-06-30 Euroceltique, S.A. Stabilized PVP-I solutions
US20170071979A1 (en) * 2011-05-11 2017-03-16 Veloce Biopharma, Llc Composition and method for treating otitis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2019040051A1 *

Also Published As

Publication number Publication date
WO2019040051A1 (en) 2019-02-28
EP3672572A1 (en) 2020-07-01
PH12020550059A1 (en) 2020-10-19

Similar Documents

Publication Publication Date Title
EP3704239A4 (en) Casz compositions and methods of use
EP3624773A4 (en) Ophthalmic compositions and methods of use
EP3432933A4 (en) Biocompatible adhesives and methods of use thereof
EP3576782A4 (en) Construct-peptide compositions and methods of use thereof
EP3704254A4 (en) Cas12c compositions and methods of use
EP3595653A4 (en) Compositions of plinabulin and use thereof
EP3245291A4 (en) Novel micro-dystrophins and related methods of use
EP3436061A4 (en) Saccharide-polypeptide conjugate compositions and methods of use thereof
EP3589319A4 (en) Glycan-interacting compounds and methods of use
EP3435956A4 (en) Photo-stabilized compositions and methods of use
EP3265096A4 (en) Ophthalmic compositions and methods of use therefor
EP3691677A4 (en) Saccharide-polypeptide conjugate compositions and methods of use thereof
EP3672523A4 (en) Single piece intra-ocular lenses and methods of manufacture thereof
EP3600372A4 (en) Synthekine compositions and methods of use
EP3886853A4 (en) Diarylhydantoin compounds and methods of use thereof
EP3829307A4 (en) Bismuth-thiol compositions and methods of use
EP3601460A4 (en) Polishing compositions and methods of use thereof
EP3247365A4 (en) Novel iodophor composition and methods of use
EP3635000A4 (en) Manabodies and methods of using
EP3402443A4 (en) Devices and compositions and methods of use thereof
EP3749691A4 (en) Angptl8-binding agents and methods of use thereof
EP3802553A4 (en) Silicon-containing compositions and their methods of use
EP3731841A4 (en) Compositions for cryopreservation and methods of use thereof
EP3713553A4 (en) Compositions and methods for treatment of eye diseases
EP3700519A4 (en) Cannabinoid compositions and methods of use therof

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200320

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20201203

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/79 20060101ALI20201127BHEP

Ipc: A61K 9/06 20060101AFI20201127BHEP

Ipc: A61K 47/20 20060101ALI20201127BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20210702